Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134727) titled 'Development of a Multimodal Prediction Model for Pseudoprogression After Radiotherapy in High-Grade Glioma' on Oct. 20.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Liuzhou Worker's Hospital
Condition:
High-gradeglioma
Intervention:
Non-pseudoprogression (non-PsP) group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-20
Target Sample Size: Non-pseudoprogression (non-PsP) group:162;Pseudoprogression (PsP) group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=348409
Disclaimer: Curat...